Coronavirus: Vaccination

Department of Health and Social Care written question – answered on 14th July 2021.

Alert me about debates like this

Photo of Justin Madders Justin Madders Shadow Minister (Health and Social Care)

To ask the Secretary of State for Health and Social Care, what discussions he has had with the European Commission on the recognition of certain AstraZeneca batches by the EU Digital Covid-19 Certificate.

Photo of Fleur Anderson Fleur Anderson Shadow Minister (Cabinet Office)

To ask the Secretary of State for Health and Social Care, what recent discussions he has had with his EU counterparts on ensuring that recipients of the AstraZeneca covid-19 vaccine are treated equitably within international travel arrangements.

Photo of Nadhim Zahawi Nadhim Zahawi Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy), The Parliamentary Under-Secretary for Health and Social Care

The Government continues to engage the European Union on certification to ensure that travel between the United Kingdom and the EU is supported by a common approach.

The Serum Institute of India (SII) manufactures Vaxzevria and Covishield and both branded vaccines are the same as the COVID-19 Oxford/AstraZeneca vaccine. All SII-made doses approved by the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzeveria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered in the UK. All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria. The European Medicines Agency has authorised Vaxzevria vaccine and it is therefore recognised by EU.

Does this answer the above question?

Yes1 person thinks so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.